Manulife (Manufacturers Life Insurance)’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-16,368
| Closed | -$63K | – | 2958 |
|
|
2020
Q1 | $63K | Buy |
16,368
+1,745
| +12% | +$6.72K | ﹤0.01% | 2690 |
|
|
2019
Q4 | $88K | Buy |
14,623
+427
| +3% | +$2.57K | ﹤0.01% | 2816 |
|
|
2019
Q3 | $110K | Buy |
14,196
+435
| +3% | +$3.37K | ﹤0.01% | 2808 |
|
|
2019
Q2 | $186K | Buy |
+13,761
| New | +$186K | ﹤0.01% | 2687 |
|
|
2018
Q3 | – | Sell |
-590
| Closed | -$6K | – | 3993 |
|
|
2018
Q2 | $6K | Sell |
590
-3,693
| -86% | -$37.6K | ﹤0.01% | 4048 |
|
|
2018
Q1 | $37K | Sell |
4,283
-3,030
| -41% | -$26.2K | ﹤0.01% | 3625 |
|
|
2017
Q4 | $92K | Buy |
7,313
+6,810
| +1,354% | +$85.7K | ﹤0.01% | 3417 |
|
|
2017
Q3 | $4K | Sell |
503
-8,853
| -95% | -$70.4K | ﹤0.01% | 4061 |
|
|
2017
Q2 | $158K | Buy |
+9,356
| New | +$158K | ﹤0.01% | 3195 |
|
|
2016
Q2 | – | Sell |
-891
| Closed | -$8K | – | 4361 |
|
|
2016
Q1 | $8K | Buy |
+891
| New | +$8K | ﹤0.01% | 3688 |
|